Literature DB >> 17495493

Comparison of 1998 WHO/ISUP and 1973 WHO classifications for interobserver variability in grading of papillary urothelial neoplasms of the bladder. Pathological evaluation of 258 cases.

Ipek Işik Gonul1, Aylar Poyraz, Ciğdem Unsal, Cenk Acar, Turgut Alkibay.   

Abstract

AIM: Our aim was to compare the interobserver variability between the 1998 WHO/ISUP and 1973 WHO classifications.
METHODS: 258 consecutive papillary urothelial carcinomas were reviewed by two pathologists and assigned a tumor grade according to the 1973 WHO and 1998 WHO/ISUP without the knowledge of primary diagnosis and clinical follow-up. All cases were also histologically staged by the two pathologists separately as follows: pTa (noninvasive), pT1 (lamina propria invasion only), pT2 (muscularis propria invasion). Findings of both pathologists and degree of agreement were compared statistically by using Pearson's chi(2) test and kappa statistics respectively. A kappa value of 0.21-0.40 is accepted as fair, 0.41-0.60 moderate and 0.61-0.80 substantial agreement.
RESULTS: Regardless of the pathologist, tumor grades of two classifications correlated to each other and the pathological stage (p < 0.05). Overall degree of agreement between pathologists was higher in the 1998 WHO/ISUP (kappa 0.59) than the 1973 WHO (kappa 0.41), but both were still moderate. Papillary urothelial neoplasia with low malignant potential was the group of 1998 WHO/ISUP that showed the lowest degree of agreement and if excluded, interobserver variability of the 1998 WHO/ISUP decreased significantly (kappa 0.84).
CONCLUSION: The diagnosis of papillary urothelial neoplasia with low malignant potential and the criteria that differentiates it from low-grade carcinomas needs improvement in order to compare the different studies and therapies and to provide more accurate information for management.

Entities:  

Mesh:

Year:  2007        PMID: 17495493     DOI: 10.1159/000100839

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  8 in total

1.  Impact of 2004 ISUP/WHO classification on bladder cancer grading.

Authors:  Soum D Lokeshwar; Roberto Ruiz-Cordero; Marie C Hupe; Merce Jorda; Mark S Soloway
Journal:  World J Urol       Date:  2015-04-02       Impact factor: 4.226

2.  Surgical management of bladder transitional cell carcinoma in a vesicular diverticulum: case report.

Authors:  Omer A Raheem; Behdad Besharatian; David P Hickey
Journal:  Can Urol Assoc J       Date:  2011-08       Impact factor: 1.862

3.  Reproductibilité des classifications OMS 1973 et OMS 2004 des tumeurs urothéliales papillaires de la vessie.

Authors:  Soumaya Ben Abdelkrim; Soumaya Rammeh; Amel Trabelsi; Lilia Ben Yacoub-Abid; Nabil Ben Sorba; Lilia Jaïdane; Moncef Mokni
Journal:  Can Urol Assoc J       Date:  2011-09-08       Impact factor: 1.862

4.  Histologic grading of urothelial papillary neoplasms: impact of combined grading (two-numbered grading system) on reproducibility.

Authors:  Burçin Tuna; Kutsal Yörükoglu; Ender Düzcan; Sait Sen; Nalan Nese; Banu Sarsık; Aysegul Akder; Sehnaz Sayhan; Uğur Mungan; Ziya Kirkali
Journal:  Virchows Arch       Date:  2011-04-12       Impact factor: 4.064

Review 5.  Reproducibility and reliability of tumor grading in urological neoplasms.

Authors:  Rainer Engers
Journal:  World J Urol       Date:  2007-09-09       Impact factor: 4.226

6.  Risk prediction scores for recurrence and progression of non-muscle invasive bladder cancer: an international validation in primary tumours.

Authors:  Moniek M Vedder; Mirari Márquez; Esther W de Bekker-Grob; Malu L Calle; Lars Dyrskjøt; Manoils Kogevinas; Ulrika Segersten; Per-Uno Malmström; Ferran Algaba; Willemien Beukers; Torben F Ørntoft; Ellen Zwarthoff; Francisco X Real; Nuria Malats; Ewout W Steyerberg
Journal:  PLoS One       Date:  2014-06-06       Impact factor: 3.240

7.  Level of mitoses in non-muscle invasive papillary urothelial carcinomas (pTa and pT1) at initial bladder biopsy is a simple and powerful predictor of clinical outcome: a multi-center study in South Korea.

Authors:  Ji Eun Kwon; Nam Hoon Cho; Yeong-Jin Choi; So Dug Lim; Yong Mee Cho; Sun Young Jun; Sanghui Park; Young A Kim; Sung-Sun Kim; Mi Sun Choe; Jung-Dong Lee; Dae Yong Kang; Jae Y Ro; Hyun-Jung Kim
Journal:  Diagn Pathol       Date:  2017-07-24       Impact factor: 2.644

8.  Reinventing diagnostics for personalized therapy in oncology.

Authors:  Diponkar Banerjee
Journal:  Cancers (Basel)       Date:  2010-06-02       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.